Swiss pharmaceutical and diagnostics giant Roche pledged on Monday to inject at least $700 million (CHF590 million) into the construction of a new plant in the United States, in the midst of a trade war. +Get the most important news from Switzerland in your inbox The Holly Spring site will eventually create around 400 jobs in the production of metabolic treatments, according to a press release from the local subsidiary Genentech. The Rhineland-based multinational already has 13 plants and 15 research and development centres in the US, employing 25,000 people. + US tariffs pressure Swiss pharma powerhouse Translated from French by DeepL/ts How we work We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The ...
